NCT04745390View on ClinicalTrials.gov

Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions
Hepatocellular CarcinomaLiver Metastases
Interventions
RADIATION

Radiation therapy

Patients will be randomized between standard of care palliative irradiation of 2000cGy in 5 fractions (Arm 1) versus radiobiologically guided dose selection also in 5 fractions (Arm 2). For all patients randomized, radiation is to be delivered in 5 fractions delivered over 5 to 15 days.

Trial Locations (1)

N6A 5W9

RECRUITING

London Regional Cancer Program, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER